Airway and cystic lung diseases can be observed in patients with Sjögren's syndrome. We report such a patient suffering of respiratory failure due to recurrent episodes of right pneumothorax, with the need of invasive mechanical ventilation. Despite thoracic drainage and adequate pneumothorax management, the patient could not be weaned from the respirator. This case is the first description of severe central excessive dynamic airway collapse in a patient with primary Sjögren's syndrome complicated by diffuse airway and cystic lung disease.
Introduction
pulmonary involvement. A labial salivary gland biopsy showed a sialiadenitis with a focus score superior to 1. At this time, CT scan studies displayed large areas of emphysema and cysts predominantly in the right lower lobe. A low-dosage systemic corticosteroid regimen was administered since the diagnosis of the PSS.
Results of Pulmonary Function testing performed 5 yrs before admission were as follows:
FVC: 1.52 L (54 % theoretical value), ERV: 0.11 L (12% theoretical value), IRV: 0.81 L, FEV 1 : 0.85 L (35 % theoretical value), RV: 5.01 (287 % theoretical value). Six months before admission, arterial blood gases results while breathing room air were as follows: pH: 7.44, P aO2 : 63 mmHg and P aCO2 : 46 mmHg. Other biological explorations showed the presence of polyclonal hypergammaglobulinemia and of anti-SSA and anti-SSB auto-antibodies. Rheumatoid factor and anti-CCP (Anti-cyclic citrullinated peptide) auto-antibodies were not detected. CT scan study displayed a frank aggravation, with large bilateral cysts. Alpha-1 antitrypsin was within the normal range (1.55 g/l). There was no evidence for lymphangiomyomatosis or histiocytosis. The patient didn't suffer from renal insufficiency. She had lived alone, had a son and had no problem for daily living activity until the 6 months preceding ICU admission.
During this period, she had been hospitalised twice because of recurrent right pneumothorax requiring thoracic drainage. She also complained of a worsening dyspnea. The systemic corticoid regimen (prednisone, 12 mg per day) was continued, but with no adjunction of any other immune-suppressive agent. The patient was finally hospitalized in another institution for a respiratory distress secondary to an acute bacterial pneumonitis, and referred to our ICU 6 days later because of hypercapnic respiratory failure with the need of invasive mechanical suggested in the present case the need for therapeutic interventions such as stent insertion, and/or reinforcement of immunosuppressive treatment, with the aim to wean the patient from mechanical ventilation (15) . Stenting under rigid bronchoscopy was therefore considered, but the
Discussion
We report the first case of severe proximal EDAC in a patient suffering from severe PSSrelated pulmonary involvement. The patient fulfilled the 2002 American-European Consensus Group European criteria for PSS (16) . While clinical pulmonary involvement can affect up to 22 % of the PSS patients (4), pulmonary cysts have also been increasingly described, with prevalence up to 46% (5, 7-13). Using high-resolution CT studies, Lohrmann reported in 24 PSS patients a high prevalence (79%) of pathological findings, with almost half of the patients displaying thin-walled cysts (5).
Bonner and Kobayashi were the firsts to describe cases of bullae formation or lung cysts in relation with Sjögren's syndrome (8, 17), with the hypothesis that lung cysts could result from airways narrowing by peribronchiolar lymphoid cellular infiltration and/or amyloid deposition, with consequent air trapping. Such a view has been widely shared, even if a correlation between cystic lesions and airways obstruction was not always found (11) . In fact, the exact mechanisms of lung cysts formation is still a matter of debate. The main advocated mechanism is therefore a partial airway obstruction, either caused by a peribronchial lymphoid cellular infiltration, as seen in lymphocytic interstitial pneumonia, or caused by an amyloid deposition, as seen in multinodular amyloidosis. These 2 conditions are known to be associated to Sjögren's syndrome.
In our case, there was no argument for a multinodular amyloidosis.
EDAC was evidenced in our patient, according to the definition proposed by Kalra and al., i.e. a pathological collapse and narrowing of the airway lumen by more than 50%, which is entirely due to the laxity of the posterior wall membrane with structurally intact airway cartilage (18) . As suggested by Kalra, EDAC could have been suspected in our patient by difficulties in weaning from the mechanical ventilation and was evidenced by fiberoptic bronchoscopy with recording of short clips (18) . CT studies performed during controlled mechanical ventilation with
Epub ahead of print papers have been peer-reviewed and accepted for publication but are posted before being copy edited and proofread, and as a result, may differ substantially when published in final version in the online and print editions of RESPIRATORY CARE. have displayed more precise informations, but was finally not considered for our patient, because of the difficulties related to the coupling of mechanical ventilation and CT-acquisitions and because of the already available results of the bronchoscopic examination (19) . Therefore, one of the main interests of the CT study in our case was to appreciate the degree of compression exerted by the cysts.
We applied in our patients the FEMOS classification system proposed by Murgu as a help to define the need for therapeutic interventions such as stent insertion, and/or reinforcement of immunosuppressive treatment for PSS, with the aim to wean the patient from mechanical ventilation (15, 20) and found it to be of value for this purpose.
In conclusion, we report a PSS patient with severe pulmonary involvement characterized by severe EDAC, mainly in relation with a PSS bronchial disease, and cystic lung disease.
Despite an unfavourable outcome, this case helps to discuss diagnostic and therapeutic strategies in such patients. 
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